Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701
Cited by
Items 101–200 of 764
Stevens, O., Claeys, K. G., Poesen, K., Saegeman, V., & Damme, P. V. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3541 · Cited by 84
Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies
Lehmann, H. C., & Hartung, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.015 · Cited by 82
Harschnitz, O., van den Berg, L. H., Johansen, L. E., Jansen, M., Kling, S., de Sá, R. V., Vlam, L., van Rheenen, W., Karst, H., Wierenga, C. J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24680 · Cited by 80
Willison, H. J., Halstead, S. K., Beveridge, E., Zitman, F. M. P., Greenshields, K. N., Morgan, B. P., & Plomp, J. J. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.028 · Cited by 79
Self-citationPeripheral Demyelinating Diseases: From Biology to Translational Medicine
Kamil, K., Yazid, M. D., Idrus, R. B. H., Das, S., & Kumar, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00087 · Cited by 80
Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment
Arnold, W. D., & Lawson, V. H. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s39592 · Cited by 79
Leonhard, S. E., Papri, N., Querol, L., Rinaldi, S., Shahrizaila, N., & Jacobs, B. C. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00580-4 · Cited by 79
Joint Task Force of the EFNS and the PNS (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00058.x · Cited by 78
An anti‐ganglioside antibody‐secreting hybridoma induces neuropathy in mice
Sheikh, K. A., Zhang, G., Gong, Y., Schnaar, R. L., & Griffin, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20173 · Cited by 77
zu Hörste, G. M., Heidenreich, H., Lehmann, H. C., Ferrone, S., Hartung, H., Wiendl, H., & Kieseier, B. C. (2009) · Glia · doi:10.1002/glia.20903 · Cited by 77
Animal Models of Autoimmune Neuropathy
Soliven, B. C. (2014) · ILAR Journal · doi:10.1093/ilar/ilt054 · Cited by 76
IgM paraproteinaemic neuropathies
Nobile‐Orazio, E. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200410000-00010 · Cited by 75
GM1/GalNAc-GD1a complex: A target for pure motor Guillain-Barré syndrome
Kaida, K., Sonoo, M., Ogawa, G., Kamakura, K., Ueda-Sada, M., Arita, M., Motoyoshi, K., & Kusunoki, S. (2008) · Neurology · doi:10.1212/01.wnl.0000335160.72184.7d · Cited by 74
Allen, D. C., Giannopoulos, K., Gray, I. A., Gregson, N. A., Makowska, A. M., Pritchard, J., & Hughes, R. A. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.0010207.x · Cited by 74
Sanvito, L., Makowska, A. M., Mahdi‐Rogers, M., Hadden, R. D. M., Peakman, M., Gregson, N. A., Nemni, R., & Hughes, R. A. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.159798 · Cited by 74
Clinical correlates of serum anti-GT1a IgG antibodies
Nagashima, T., Koga, M., Odaka, M., Hirata, K., & Yuki, N. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.01.005 · Cited by 74
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
Stathopoulos, P., & Dalakas, M. C. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01196-w · Cited by 73
IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN
Piepers, S., Jansen, M., Cats, E. A., van Sorge, N. M., van den Berg, L. H., & van der Pol, W. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.023 · Cited by 73
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification
Eldar, A. H., & Chapman, J. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.033 · Cited by 73
Isolated insular infarction eliminates contralateral cold, cold pain, and pinprick perception
Birklein, F., Rolke, R., & Müller-Forell, W. (2005) · Neurology · doi:10.1212/01.wnl.0000181351.82772.b3 · Cited by 68
Bibliometric analysis of publications on Campylobacter: (2000–2015)
Sweileh, W. M., Al‐Jabi, S. W., Sawalha, A. F., AbuTaha, A. S., & Zyoud, S. H. (2016) · Journal of Health Population and Nutrition · doi:10.1186/s41043-016-0076-7 · Cited by 72
Kusunoki, S., Kaida, K., & Ueda, M. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.10.001 · Cited by 71
Severity of Guillain–Barré syndrome is associated with Fcγ Receptor III polymorphisms
van Sorge, N. M., van der Pol, W. L., Jansen, M., Geleijns, K. P. W., Kalmijn, S., Hughes, R. A., Rees, J. H., Pritchard, J., Vedeler, C. A., Myhr, K., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.016 · Cited by 71
Ganglioside mimicry as a cause of Guillain–Barré syndrome
Yuki, N., & Odaka, M. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000174604.42272.2d · Cited by 69
Immune circuitry in the peripheral nervous system
Kieseier, B. C., Hartung, H., & Wiendl, H. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000245365.51823.72 · Cited by 69
Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum
Muthana, S. M., & Gildersleeve, J. C. (2016) · Scientific Reports · doi:10.1038/srep19509 · Cited by 68
Halstead, S. K., Morrison, I., O’Hanlon, G. M., Humphreys, P. D., Goodfellow, J. A., Plomp, J. J., & Willison, H. J. (2005) · Glia · doi:10.1002/glia.20228 · Cited by 68
Self-citationJacobs, B. C., Koga, M., van Rijs, W., Geleijns, K. P. W., van Doorn, P. A., Willison, H. J., & Yuki, N. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.017 · Cited by 68
Self-citationImmune responses to myelin proteins in Guillain-Barre syndrome
Makowska, A. M., Pritchard, J., Sanvito, L., Gregson, N. A., Peakman, M., Hayday, A., & Hughes, R. A. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.123943 · Cited by 67
GD1b-specific antibody induces ataxia in Guillain-Barré syndrome
Kaida, K., Kamakura, K., Ogawa, G., Ueda, M., Motoyoshi, K., Arita, M., & Kusunoki, S. (2008) · Neurology · doi:10.1212/01.wnl.0000317093.57106.33 · Cited by 67
An update on electrophysiological studies in neuropathy
Krarup, C. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200310000-00007 · Cited by 67
Immunomodulatory Therapies in Neurologic Critical Care
McDaneld, L. M., Fields, J. D., BOURDETTE, D. N., & Bhardwaj, A. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9274-0 · Cited by 66
Metabolic pathways and intracellular trafficking of gangliosides
Daniotti, J. L., & Iglesias‐Bartolomé, R. (2011) · IUBMB Life · doi:10.1002/iub.477 · Cited by 66
Sinha, S., Prasad, K. N., Jain, D. K., Pandey, C. M., Jha, S., & Pradhan, S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01636.x · Cited by 66
Sheikh, K. A. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000929 · Cited by 65
Serum anti-Glc(α1,4)Glc(α) antibodies as a biomarker for relapsing–remitting multiple sclerosis
Schwarz, M., Spector, L., Gortler, M., Weisshaus, O., Glass‐Marmor, L., Karni, A., Dotan, N., & Miller, A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.12.006 · Cited by 65
Zika virus and neurologic autoimmunity: the putative role of gangliosides
Anaya, J., Ramírez-Santana, C., Salgado-Castaneda, I., Chang, C. C.-C., Ansari, A. A., & Gershwin, M. E. (2016) · BMC Medicine · doi:10.1186/s12916-016-0601-y · Cited by 65
Bacterial infections in Guillain-Barré and Fisher syndromes
Yuki, N., & Koga, M. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000245367.36576.e9 · Cited by 64
Cellular and humoral immune abnormalities in Gulf War veterans.
Vojdani, A., & Thrasher, J. D. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6881 · Cited by 64
Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome
Kaida, K.-I., Kusunoki, S., Kanzaki, M., Kamakura, K., Motoyoshi, K., & Kanazawa, I. (2004) · Neurology · doi:10.1212/01.wnl.0000113718.27729.43 · Cited by 64
Gray, M. R., Thrasher, J. D., Crago, R., Madison, R., Arnold, L. J., Campbell, A. W., & Vojdani, A. (2003) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.2003.11879142 · Cited by 64
Willison, H. J., Townson, K., Veitch, J., Boffey, J., Isaacs, N., Andersen, S. M., Zhang, P., Ling, C.-C., & Bundle, D. R. (2003) · Brain · doi:10.1093/brain/awh083 · Cited by 63
Self-citationBerger, M., McCallus, D. E., & Lin, C. S.-Y. (2013) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12048 · Cited by 61
Review: Pathogenesis and treatment of immune-mediated neuropathies
Lehmann, H. C., zu Hörste, G. M., Kieseier, B. C., & Hartung, H. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609104792 · Cited by 61
Illés, Z., & Blaabjerg, M. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00009-5 · Cited by 60
Ariga, T., & Yu, R. K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20395 · Cited by 60
The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents
Toyka, K. V., & Gold, R. (2003) · Neurology · doi:10.1212/wnl.60.8_suppl_3.s2 · Cited by 60
Childhood acute and chronic immune-mediated polyradiculoneuropathies
Rabie, M., & Nevo, Y. (2008) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.04.009 · Cited by 58
Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation
He, L., Zhang, G., Liu, W., Gao, T., & Sheikh, K. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4926-14.2015 · Cited by 57
Islam, Z., van Belkum, A., Wagenaar, J. A., Cody, A. J., de Boer, A. G., Tabor, H., Jacobs, B. C., Talukder, K. A., & Endtz, H. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007257 · Cited by 57
Inactivated influenza vaccines
Bridges, C. B., Katz, J. M., Levandowski, R. A., & Cox, N. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50019-2 · Cited by 56
Mold and Mycotoxins: Effects on the Neurological and Immune Systems in Humans
Campbell, A. W., Thrasher, J. D., Gray, M. R., & Vojdani, A. (2004) · Advances in applied microbiology · doi:10.1016/s0065-2164(04)55015-3 · Cited by 56
Paranodal and other autoantibodies in chronic inflammatory neuropathies
Querol, L., & Illa, I. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000233 · Cited by 56
Yao, D., McGonigal, R., Barrie, J. A., Cappell, J., Cunningham, M. E., Meehan, G. R., Fewou, S. N., Edgar, J. M., Rowan, E., Ohmi, Y., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3996-13.2014 · Cited by 48
Self-citationAnti-ganglioside antibodies alter presynaptic release and calcium influx
Buchwald, B., Zhang, G., Vogt-Eisele, A. K., Zhang, W., Ahangari, R., Griffin, J. W., Hatt, H. H., Toyka, K. V., & Sheikh, K. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.008 · Cited by 55
Poly, F., Read, T. D., Chen, Y., Monteiro, M. A., Serichantalergs, O., Pootong, P., Bodhidatta, L., Mason, C. J., Rockabrand, D., Baqar, S., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00780-08 · Cited by 55
Structural requirements of anti-GD1a antibodies determine their target specificity
López, P. H. H., Zhang, G., Bianchet, M. A., Schnaar, R. L., & Sheikh, K. A. (2008) · Brain · doi:10.1093/brain/awn074 · Cited by 55
Treatment of Guillain‐Barré syndrome and CIDP
van Doorn, P. A. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.0010203.x · Cited by 55
Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss
Garg, N., Howells, J., Yiannikas, C., Vucic, S., Krishnan, A. V., Spies, J. M., Bostock, H., Mathey, E. K., Pollard, J. D., Park, S. B., et al. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.07.414 · Cited by 54
Papini, A. M. (2009) · Journal of Peptide Science · doi:10.1002/psc.1166 · Cited by 54
Activity-dependent conduction block in multifocal motor neuropathy: Magnetic fatigue test
Nodera, H., Bostock, H., Izumi, Y., Nakamura, K., Urushihara, R., Sakamoto, T., Murase, N., Shimazu, H., Kusunoki, S., & Kaji, R. (2006) · Neurology · doi:10.1212/01.wnl.0000225048.20239.e4 · Cited by 54
Complement activity is associated with disease severity in multifocal motor neuropathy
Vlam, L., Cats, E. A., Harschnitz, O., Jansen, M., Piepers, S., Veldink, J. H., Franssen, H., Stork, A. C. J., Heezius, E., Rooijakkers, S. H. M., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000119 · Cited by 54
Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair
Lopez, P. H., Zhang, G., Zhang, J., Lehmann, H. C., Griffin, J. W., Schnaar, R. L., & Sheikh, K. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2281-10.2010 · Cited by 54
Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
Muthana, S. M., Xia, L., Campbell, C. T., Zhang, Y., & Gildersleeve, J. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119298 · Cited by 53
Recent developments and future directions in Guillain‐Barré syndrome
Lehmann, H. C., Hughes, R. A., Kieseier, B. C., & Hartung, H. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00433.x · Cited by 53
Govoni, V., Granieri, E., Manconi, M., Capone, J. G., & Casetta, I. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00215-6 · Cited by 53
Usuki, S., Sanchez, J., Ariga, T., Utsunomiya, I., Taguchi, K., Rivner, M. H., & Yu, R. K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.01.007 · Cited by 52
Origin of ganglioside complex antibodies in Guillain–Barré syndrome
Kuijf, M. L., Godschalk, P. C. R., Gilbert, M., Endtz, H. P., Tio‐Gillen, A. P., Ang, C. W., van Doorn, P. A., & Jacobs, B. C. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.014 · Cited by 51
B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target
Dalakas, M. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.005 · Cited by 51
Guillain-Barré syndrome after COVID-19 in Japan
Hirayama, T., Hongo, Y., Kaida, K., & Kano, O. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-239218 · Cited by 50
Autoimmune diseases of the peripheral nervous system
Kieseier, B. C., Lehmann, H. C., & zu Hörste, G. M. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.011 · Cited by 50
Göebel, A., Vogel, H., Caneris, O. A., Bajwa, Z. H., Clover, L. M., Roewer, N., Schedel, R., Karch, H., Sprotte, G., & Vincent, A. C. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.018 · Cited by 50
Yonekura, K., Yokota, S., Tanaka, S., KUBOTA, H. Y., Fujii, N., Matsumoto, H., & Chiba, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.017 · Cited by 50
The role of chemokines in guillain–barré syndrome
Chiang, S., & Ubogu, E. E. (2013) · Muscle & Nerve · doi:10.1002/mus.23829 · Cited by 50
Campylobacter jejuni/coli Infection: Is It Still a Concern?
Veronese, P., & Dodi, I. (2024) · Microorganisms · doi:10.3390/microorganisms12122669 · Cited by 49
Pukin, A. V., Weijers, C. A. G. M., van Lagen, B., Wechselberger, R. W., Sun, B., Gilbert, M., Karwaski, M.-F., Florack, D. E. A., Jacobs, B. C., Tio‐Gillen, A. P., et al. (2008) · Carbohydrate Research · doi:10.1016/j.carres.2008.01.007 · Cited by 49
Shala, A., Regazzoni, L., Daci, A., Orioli, M., Brezovska, K., Panovska, A. P., Beretta, G., & Šuturkova, L. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.005 · Cited by 49
The complement system in the peripheral nerve: Friend or foe?
Ramaglia, V., Daha, M. R., & Baas, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.018 · Cited by 49
Botulinum neurotoxin serotype D is poorly effective in humans: An in vivo electrophysiological study
Eleopra, R., Montecucco, C., Devigili, G., Lettieri, C., Rinaldo, S., Verriello, L., Pirazzini, M., Caccin, P., & Rossetto, O. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.11.004 · Cited by 48
Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody
Horwacik, I., Golik, P., Grudnik, P., Kolinski, M., Zdzalik, M., Rokita, H., & Dubin, G. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.052720 · Cited by 44
Anti-glycan antibodies: roles in human disease
Temme, J. S., Butler, D. L., & Gildersleeve, J. C. (2021) · Biochemical Journal · doi:10.1042/bcj20200610 · Cited by 48
Conrad, K., Schneider, H., Ziemssen, T., Talaska, T., Reinhold, D., Humbel, R., & Roggenbuck, D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.031 · Cited by 48
Anti-Ganglioside Antibody-Mediated Activation of RhoA Induces Inhibition of Neurite Outgrowth
Zhang, G., Lehmann, H. C., Manoharan, S., Hashmi, M., Shim, S., Ming, G.-L., Schnaar, R. L., Lopez, P. H., Bogdanova, N., & Sheikh, K. A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3829-10.2011 · Cited by 45
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Hahn, A. F., Hartung, H., & Dyck, P. J. B. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50102-2 · Cited by 48
Fewou, S. N., Rupp, A., Nickolay, L. E., Carrick, K., Greenshields, K. N., Pediani, J. D., Plomp, J. J., & Willison, H. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59110 · Cited by 47
Self-citationWorstell, N. C., Krishnan, P., Weatherston, J. D., & Wu, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153265 · Cited by 47
Siglecs at the Host–Pathogen Interface
Chang, Y., & Nizet, V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1580-4_8 · Cited by 47
Tatsumoto, M., Koga, M., Gilbert, M., Odaka, M., Hirata, K., Kuwabara, S., & Yuki, N. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.04.005 · Cited by 47
Townson, K. H., Boffey, J., Nicholl, D., Veitch, J., Bundle, D. R., Zhang, P., Samain, E., Antoine, T., Bernardi, A., Arosio, D., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl074 · Cited by 47
Self-citationSchmidt‐Ott, R., Schmidt, H., Feldmann, S., Brass, F., Krone, B., & Groß, U. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00065-06 · Cited by 47
MANAGEMENT OF INFLAMMATORY NEUROPATHIES
Hadden, R. D. M., & Hughes, R. A. C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.suppl_2.ii9 · Cited by 47
Pathophysiology of immune-mediated demyelinating neuropathies-Part II: Neurology
Franssen, H., & Straver, D. C. G. (2013) · Muscle & Nerve · doi:10.1002/mus.24068 · Cited by 46
Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG
Ilyas, A. A., Gu, Y., Dalakas, M. C., Quarles, R. H., & Bhatt, S. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.025 · Cited by 46
The pathogenesis of multifocal motor neuropathy and an update on current management options
Léger, J., Guimarães‐Costa, R., & Ferfoglia, R. I. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615575269 · Cited by 46
Soltani, Z. E., Rahmani, F., & Rezaei, N. (2019) · European Cytokine Network · doi:10.1684/ecn.2019.0424 · Cited by 45
The clinical value of therapeutic plasma exchange in multifocal motor neuropathy
Lehmann, H. C., Hoffmann, F. R., Fußhöller, A., zu Hörste, G. M., Hetzel, R., Hartung, H., Schroeter, M., & Kieseier, B. C. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.02.022 · Cited by 45
NMR evidence of GM1-induced conformational change of Substance P using isotropic bicelles
Gayen, A., Goswami, S. K., & Mukhopadhyay, C. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.09.023 · Cited by 44
Primary Cilia in Glial Cells: An Oasis in the Journey to Overcoming Neurodegenerative Diseases
Ki, S. M., Jeong, H. S., & Lee, J. E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736888 · Cited by 40
Fujimura, H. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00021-7 · Cited by 44
Anti‐ GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis
Rupp, A., Galban‐Horcajo, F., Bianchi, E., Dondi, M., Penderis, J., Cappell, J., Burgess, K. E., Matiasek, K., McGonigal, R., & Willison, H. J. (2013) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12011 · Cited by 44
Self-citation
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.